Serotonin 6 receptor gene and mood disorders: Case–control study and meta-analysis

[1]  R. Yoshimura,et al.  HTR2A is Associated with SSRI Response in Major Depressive Disorder in a Japanese Cohort , 2010, NeuroMolecular Medicine.

[2]  Daniel F. Gudbjartsson,et al.  Parental origin of sequence variants associated with complex diseases , 2009, Nature.

[3]  K. Hashimoto,et al.  Preliminary genome‐wide association study of bipolar disorder in the Japanese population , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[4]  G. Papakostas.  Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder. , 2009, The Journal of clinical psychiatry.

[5]  Judy H. Cho,et al.  Finding the missing heritability of complex diseases , 2009, Nature.

[6]  M. Ikeda,et al.  Serotonin 1A receptor gene and major depressive disorder: an association study and meta-analysis , 2009, Journal of Human Genetics.

[7]  T. Lehtimäki,et al.  5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression , 2009, Neuroreport.

[8]  M. Ikeda,et al.  Orphan Nuclear Receptor Rev-erb Alpha Gene (NR1D1) and Fluvoxamine Response in Major Depressive Disorder in the Japanese Population , 2009, Neuropsychobiology.

[9]  J. Calabrese,et al.  Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder. , 2009, Journal of affective disorders.

[10]  M. Ikeda,et al.  BDNF is not associated with schizophrenia: Data from a Japanese population study and meta-analysis , 2009, Schizophrenia Research.

[11]  M. Ikeda,et al.  Possible Association of Prokineticin 2 Receptor Gene (PROKR2) with Mood Disorders in the Japanese Population , 2009, NeuroMolecular Medicine.

[12]  M. Ikeda,et al.  Genetic association analysis of serotonin 2A receptor gene (HTR2A) with bipolar disorder and major depressive disorder in the Japanese population , 2009, Neuroscience Research.

[13]  M. Tohen,et al.  Antipsychotic agents in the treatment of bipolar mania. , 2009, Bipolar disorders.

[14]  M. Berk,et al.  Medicating mood with maintenance in mind: bipolar depression pharmacotherapy. , 2009, Bipolar disorders.

[15]  S. Kulkarni,et al.  Current investigational drugs for major depression , 2009, Expert opinion on investigational drugs.

[16]  M. Ikeda,et al.  Meta-analysis of association between genetic variants in COMT and schizophrenia: An update , 2009, Schizophrenia Research.

[17]  M. Ikeda,et al.  CLOCK may Predict the Response to Fluvoxamine Treatment in Japanese Major Depressive Disorder Patients , 2009, NeuroMolecular Medicine.

[18]  M. Ikeda,et al.  Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population , 2009, European Archives of Psychiatry and Clinical Neuroscience.

[19]  M. Ikeda,et al.  Association analysis of nuclear receptor Rev-erb alpha gene (NR1D1) with mood disorders in the Japanese population , 2008, Neuroscience Research.

[20]  J. Amsterdam,et al.  Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study. , 2008, The Journal of clinical psychiatry.

[21]  Catherine J. Harmer,et al.  Serotonin and emotional processing: Does it help explain antidepressant drug action? , 2008, Neuropharmacology.

[22]  P. Albert,et al.  Transcriptional regulation at a HTR1A polymorphism associated with mental illness , 2008, Neuropharmacology.

[23]  K. Fone.  An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function , 2008, Neuropharmacology.

[24]  C. Spencer,et al.  Identification of loci associated with schizophrenia by genome-wide association and follow-up , 2008, Nature Genetics.

[25]  Charles A. Marsden,et al.  A role for the 5-HT1A, 5-HT4 and 5-HT6 receptors in learning and memory , 2008 .

[26]  S. Gabriel,et al.  Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder , 2008, Nature Genetics.

[27]  S. Gabriel,et al.  Whole-genome association study of bipolar disorder , 2008, Molecular Psychiatry.

[28]  A. Wesołowska,et al.  Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats , 2007, Behavioural pharmacology.

[29]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[30]  A. Wesołowska,et al.  Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression , 2007, Neuropharmacology.

[31]  Tadafumi Kato,et al.  Molecular genetics of bipolar disorder and depression , 2007, Psychiatry and clinical neurosciences.

[32]  D. Levinson.  The Genetics of Depression: A Review , 2006, Biological Psychiatry.

[33]  T. Gilliam,et al.  Genome-wide linkage scan in a large bipolar disorder sample from the National Institute of Mental Health genetics initiative suggests putative loci for bipolar disorder, psychosis, suicide, and panic disorder , 2006, Molecular Psychiatry.

[34]  S. Cichon,et al.  Genomewide scan and fine-mapping linkage studies in four European samples with bipolar affective disorder suggest a new susceptibility locus on chromosome 1p35-p36 and provides further evidence of loci on chromosome 4q31 and 6q24. , 2005, American journal of human genetics.

[35]  Seung-Hwan Lee,et al.  Association between the 5‐HT6 receptor C267T polymorphism and response to antidepressant treatment in major depressive disorder , 2005, Psychiatry and clinical neurosciences.

[36]  M. Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[37]  G. Abecasis,et al.  Genome-wide linkage analysis of a composite index of neuroticism and mood-related scales in extreme selected sibships. , 2004, Human molecular genetics.

[38]  P. Sham,et al.  The future of association studies: gene-based analysis and replication. , 2004, American journal of human genetics.

[39]  F. Dudbridge.  Pedigree disequilibrium tests for multilocus haplotypes , 2003, Genetic epidemiology.

[40]  M. Teitler,et al.  Creation, expression, and characterization of a constitutively active mutant of the human serotonin 5‐HT6 receptor , 2003, Synapse.

[41]  Jason H. Moore,et al.  Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions , 2003, Bioinform..

[42]  F. Bymaster,et al.  Potent antagonism of 5-HT(3) and 5-HT(6) receptors by olanzapine. , 2001, European journal of pharmacology.

[43]  D. Middlemiss,et al.  Characterization of [125I]‐SB‐258585 binding to human recombinant and native 5‐HT6 receptors in rat, pig and human brain tissue , 2000 .

[44]  S. Cichon,et al.  Investigation of the human serotonin 6 [5-HT6] receptor gene in bipolar affective disorder and schizophrenia. , 2000, American journal of medical genetics.

[45]  S. Tsai,et al.  Association analysis of the 5-HT(6) receptor polymorphism (C267T) in mood disorders. , 1999, American journal of medical genetics.

[46]  L. Lanfumey,et al.  Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system , 1997, Brain Research.

[47]  D. Sibley,et al.  Cloning, Characterization, and Chromosomal Localization of a Human 5‐HT6 Serotonin Receptor , 1996, Journal of neurochemistry.

[48]  S. Watson,et al.  Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain — a combined in situ hybridisation/in vitro receptor autoradiographic study , 1991, Brain Research.

[49]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[50]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.

[51]  C. Debattista,et al.  Utility of Atypical Antipsychotics in the Treatment of Resistant Unipolar Depression , 2009, CNS drugs.

[52]  F. Boaretto,et al.  Genome-wide scan supports the existence of a susceptibility locus for schizophrenia and bipolar disorder on chromosome 15q26 , 2007, Molecular Psychiatry.

[53]  Pak Chung Sham,et al.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits , 2003, Bioinform..